How does late nephrological co-management impact chronic kidney disease? - An observational study

International Journal of Clinical Practice

Volumn 64, Issue 13, 2010, Pages 1784-1792

  Herget Rosenthal, S ^a,b   Quellmann, T ^a   Linden, C ^a   Hollenbeck, M ^c   Jankowski, V ^d   Kribben, A ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Rotes Kreuz Krankenhaus   (Germany)

^c Knappschaftskrankenhaus ^*  (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BICARBONATE; C REACTIVE PROTEIN; CALCIUM; CREATININE; HEMOGLOBIN A1C; PARATHYROID HORMONE; PHOSPHORUS; POTASSIUM;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; BICARBONATE BLOOD LEVEL; BLOOD PRESSURE REGULATION; BODY MASS; BONE DISEASE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; EARLY REFERRAL; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY POLYCYSTIC DISEASE; LATER REFERRAL; LENGTH OF STAY; LUNG EDEMA; MALE; MALNUTRITION; METABOLIC ACIDOSIS; MORBIDITY; MORTALITY; NUTRITIONAL STATUS; OBSERVATIONAL STUDY; OBSTRUCTIVE UROPATHY; PARATHYROID HORMONE BLOOD LEVEL; PATIENT REFERRAL; POTASSIUM BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

AGED; DELAYED DIAGNOSIS; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; HOSPITAL MORTALITY; HUMANS; KIDNEY FAILURE, CHRONIC; LENGTH OF STAY; MALE; MIDDLE AGED; QUALITY OF HEALTH CARE; REFERRAL AND CONSULTATION; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 78649236895     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02535.x     Document Type: Article

References (31)

1. El Nahas AM, Bello AK,. Chronic kidney disease: the global challenge. Lancet 2005; 365: 331 - 40.
2. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038 - 47.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296 - 305.
4. Khan SS, Kazmi WH, Abichandani R, Tighiouart H, Pereira BJ, Kausz AT,. Health care utilization among patients with chronic kidney disease. Kidney Int 2002; 62: 229 - 36.
5. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl. 2): S1 - S266.
6. Locatelli F, Aljama P, Barany P, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 2004; 19 (Suppl. 2): 1 - 47.
7. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2002; 25 (Suppl. 1): S33 - S49.
8. National Kidney Foundation. K/DOQI clinical practice guidelines: bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42 (Suppl. 3): S1 - S201.
9. National Kidney Foundation. K/DOQI clinical practice guidelines for nutrition in chronic kidney disease. Am J Kidney Dis 2000; 35 (Suppl. 2): S1 - S140.
10. Kidney Disease Outcomes Quality Initiative (K/DOQI) Group. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease Am J Kidney Dis 2003; 41 (4 Suppl. 3): S1 - S91.
11. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 2002; 137: 479 - 86.
12. Kessler M, Frimat L, Panescu V, Briancon S,. Impact of nephrological referral on early and midterm outcome in ESRD: epidemiologie de l'insuffisance renale chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study. Am J Kidney Dis 2003; 42: 474 - 85.
13. Schwenger V, Hofmann A, Khalifeh N, et al. Uremic patients: late referral - early death. Dtsch Med Wochenschr 2003; 128: 1216 - 20.
14. Roderick P, Jones C, Drey N, et al. Late referral for end-stage renal disease: a region-wide survey in the south west of England. Nephrol Dial Transplant 2002; 17: 1252 - 9.
15. Chan MR, Dall AT, Fletcher KE, Lu N, Trivedi H,. Outcomes in patients with chronic kidney disease referred late to nephrologists: a meta-analysis. Am J Med 2007; 120: 1063 - 70.
16. Tseng CL, Kern EF, Miller DR, et al. Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med 2008; 168: 55 - 62.
17. McClellan WM, Wasse H, McClellan AC, Kipp A, Waller LA, Rocco MV,. Treatment center and geographic variability in pre-ESRD care associate with increase mortality. J Am Soc Nephrol 2009; 20: 1078 - 85.
18. Winkelmayer WC, Owen WF, Levin R, Avorn J,. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 2003; 14: 486 - 92.
19. Traynor JP, Simpson K, Geddes CC, Deighan CJ, Fox JG,. Early initiation of dialysis fails to prolong survival in patients with end-stage renal failure. J Am Soc Nephrol 2002; 13: 2125 - 32.
20. Shariff SZ, Cuerden MS, Jain AK, Garg AX,. The secret of immortal time bias in epidemiologic studies. J Am Soc Nephrol 2008; 19: 841 - 3.
21. Herget-Rosenthal S, Quellmann T, Linden C, Reinhardt W, Philipp T, Kribben A,. Management of advanced chronic kidney disease in primary care - current data from Germany. Int J Clin Pract 2006; 60: 941 - 8.
22. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247 - 54.
23. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM,. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993; 341: 415 - 8.
24. De Nicola L, Minutolo R, Chiodini P, et al. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int 2006; 69: 538 - 45.
25. Bailie GR, Eisele G, Liu L, et al. Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects. Nephrol Dial Transplant 2005; 20: 1110 - 5.
26. Minutolo R, De Nicola L, Bamboli P, et al. Management of hypertension in patients with CKD: differences between primary and tertiary care settings. Am J Kidney Dis 2005; 46: 18 - 25.
27. Lorenzo V, Martn M, Rufino M, Hernandez D, Torres A, Ayus JC,. Predialysis nephrologic care and a functioning arteriovenous fistula at entry are associated with better survival in incident hemodialysis patients: an observational cohort study. Am J Kidney Dis 2004; 43: 999 - 1007.
28. Nigwekar SU, Navaneethan SD,. Timely referral alone may not be enough for patients with chronic kidney disease. Mayo Clin Proc 2007; 82: 252 - 3.
29. John R, Webb M, Young A, Stevens PE,. Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis 2004; 43: 825 - 35.
30. Lu CY,. Observational studies: a review of study designs, challenges and strategies to reduce confounding. Int J Clin Pract 2009; 63: 691 - 7.
31. Curtis BM, Barrett BJ, Djurdjev O, Singer J, Levin A,. Evaluation and treatment of CKD patients before and at first nephrologists encounter in Canada. Am J Kidney Dis 2007; 50: 733 - 42.